Anvisa autoriza retomada de produção na Ypê após reinspeção

Brazil's health regulator gave the green light this week for Ypê, one of the country's largest household products manufacturers, to resume production at its factory in the interior of São Paulo state. The authorization came after a joint inspection that ran from Thursday through Friday of last week, conducted by Anvisa—the national health surveillance agency—alongside local health authorities from the state capital, the Campinas region, and the municipality of Amparo, where the plant operates.

The company can now manufacture and sell liquid laundry detergent, liquid dish soap, and disinfectants with lot numbers ending in 1, provided they were made on or after April 1st of this year. Products bearing the same lot designation but manufactured before that date remain off the market. Those older batches must stay in secure storage and cannot be discarded; they will only be released once Ypê submits laboratory certifications from testing facilities approved by Anvisa.

The factory had been partially shut down on May 7th after regulators identified a risk of microbial contamination in products made there. The concern centered on Pseudomonas aeruginosa, a bacterium commonly found in air, water, soil, and even on the skin of healthy people. While it rarely infects people with functioning immune systems, it can trigger or worsen infections in those whose immunity is compromised. This distinction shaped how Ypê communicated the earlier problem—the company directed warnings specifically at immunosuppressed individuals, their caregivers, and healthcare workers.

The shutdown itself traced back to an inspection conducted between April 27th and 30th, when regulators examined the liquid product lines at the Amparo facility. That inspection uncovered 76 sanitary deficiencies. Ypê responded by halting two production lines and submitting a corrective action plan to address each identified gap. When inspectors returned last week, they found that the company had made the necessary improvements to both the production lines and quality control systems.

Leandro Safatle, Anvisa's president, visited the facility and stated that the factory now possessed the conditions required to operate safely and provide products free of health risk to the Brazilian public. The authorization, however, came with a wrinkle: Anvisa initially announced that both manufacturing and sales had been cleared, then quickly corrected course to say only production had resumed, and finally updated its statement to confirm that commercialization and use were also permitted.

The current situation is rooted in an earlier episode. In November of last year, Ypê had announced a voluntary precautionary recall after discovering Pseudomonas aeruginosa exclusively in its liquid laundry detergent. Though Anvisa acknowledged that historical contamination incident as part of the company's regulatory record, the agency emphasized that this week's decision rested on the findings from the April inspection alone, not the November case.

Products made before April 1st remain in limbo. They cannot be sold or used, and they cannot be thrown away. Their fate depends entirely on whether Ypê can produce laboratory reports from Anvisa-approved testing centers confirming their safety. Until those certifications arrive, the older batches will sit in storage—a holding pattern that underscores the stakes of the contamination risk and the caution with which regulators are proceeding.